Kallam Anji Reddy - Dr Reddy's Labs

Dr Reddy's Labs

Dr. Reddy's Laboratories has been credited with turning the Indian bulk drug industry from dependence on imports in the mid 1980s to self reliance in the mid 1990s and finally into the export-oriented industry that it is today. It was the first company to take up drug discovery research in India (in 1993). In April 2001 Dr Reddy’s Labs became the first Asian pharmaceutical company outside Japan to be listed on the New York Stock Exchange. The company has revenues of $546 million (Rs.2,427 crore) during the fiscal year 2006 and is India’s second largest pharmaceutical company.